AZENTA INC (AZTA) Stock Price & Overview

NASDAQ:AZTA • US1143401024

Current stock price

19.9 USD
-1.41 (-6.62%)
At close:
19.9 USD
0 (0%)
After Hours:

The current stock price of AZTA is 19.9 USD. Today AZTA is down by -6.62%. In the past month the price decreased by -26.24%. In the past year, price decreased by -42.5%.

AZTA Key Statistics

52-Week Range19.87 - 41.73
Current AZTA stock price positioned within its 52-week range.
1-Month Range19.87 - 26.55
Current AZTA stock price positioned within its 1-month range.
Market Cap
916.594M
P/E
36.85
Fwd P/E
18.68
EPS (TTM)
0.54
Dividend Yield
N/A

AZTA Stock Performance

Today
-6.62%
1 Week
-1.44%
1 Month
-26.24%
3 Months
-42.73%
Longer-term
6 Months -30.32%
1 Year -42.50%
2 Years -66.99%
3 Years -55.40%
5 Years N/A
10 Years N/A

AZTA Stock Chart

AZENTA INC / AZTA Daily stock chart

AZTA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to AZTA. When comparing the yearly performance of all stocks, AZTA is a bad performer in the overall market: 92.26% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AZTA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AZTA. While AZTA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AZTA Earnings

On February 4, 2026 AZTA reported an EPS of 0.09 and a revenue of 148.64M. The company missed EPS expectations (-35.95% surprise) and missed revenue expectations (-0.98% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 4, 2026
PeriodQ1 / 2026
EPS Reported$0.09
Revenue Reported148.642M
EPS Surprise -35.95%
Revenue Surprise -0.98%

AZTA Forecast & Estimates

14 analysts have analysed AZTA and the average price target is 38.47 USD. This implies a price increase of 93.31% is expected in the next year compared to the current price of 19.9.

For the next year, analysts expect an EPS growth of 51.54% and a revenue growth 4.92% for AZTA


Analysts
Analysts77.14
Price Target38.47 (93.32%)
EPS Next Y51.54%
Revenue Next Year4.92%

AZTA Groups

Sector & Classification

AZTA Financial Highlights

Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 14.89% compared to the year before.


Income Statements
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Industry RankSector Rank
PM (TTM) N/A
ROA -2.79%
ROE -3.37%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%12.5%
Sales Q2Q%0.77%
EPS 1Y (TTM)14.89%
Revenue 1Y (TTM)-8.4%

AZTA Ownership

Ownership
Inst Owners115.54%
Shares46.06M
Float45.60M
Ins Owners0.69%
Short Float %10.24%
Short Ratio5.85

About AZTA

Company Profile

AZTA logo image Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Company Info

IPO: 1995-02-02

AZENTA INC

200 Summit Drive, 6Th Floor

Burlington MASSACHUSETTS US

Employees: 3000

AZTA Company Website

AZTA Investor Relations

Phone: 19782622400

AZENTA INC / AZTA FAQ

Can you describe the business of AZENTA INC?

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.


What is the stock price of AZENTA INC today?

The current stock price of AZTA is 19.9 USD. The price decreased by -6.62% in the last trading session.


Does AZENTA INC pay dividends?

AZTA does not pay a dividend.


How is the ChartMill rating for AZENTA INC?

AZTA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is AZENTA INC (AZTA) stock traded?

AZTA stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of AZENTA INC (AZTA)?

The PE ratio for AZENTA INC (AZTA) is 36.85. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 19.9 USD.


What is the employee count for AZTA stock?

AZENTA INC (AZTA) currently has 3000 employees.